Generic Lucemyra is indicated for symptoms associated with acute withdrawal from opioids and for facilitation of the completion of opioid discontinuation treatment.
Brimonidine Tartrate Ophthalmic Solution, 0.1%, is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.